AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33848906 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint Induced Movement Therapy (CIMT)
Number of subjects: 30
Study 33848906 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 30
Study 34448951 — intervention group
Group type: EXPERIMENTAL
Intervention: Cone beam CT (CBCT)
Number of subjects: 60
Study 34448951 — intervention group
Group type: COMPARATOR
Intervention: Intraoral radiographs
Number of subjects: 60
Study 33351194 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy at 2 l.kg-1.min-1
Number of subjects: 30
Study 33351194 — intervention group
Group type: COMPARATOR
Intervention: High-flow nasal therapy at 4 l.kg-1.min-1
Number of subjects: 30
Study 32527329 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin cancer preventive behaviors (wearing sun-blocking clothing, using sunscreen cream, wearing a cap, using gloves and sunglasses)
Number of subjects: 243
Study 32527329 — intervention group
Group type: EXPERIMENTAL
Intervention: Protection motivation theory and per capita income
Number of subjects: 243
Study 32527329 — intervention group
Group type: EXPERIMENTAL
Intervention: Response efficacy construct
Number of subjects: 243
Study 32527329 — intervention group
Group type: EXPERIMENTAL
Intervention: Per capita income
Number of subjects: 243
Study 32527329 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivation
Number of subjects: 243
Study 36151010 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 Hz stimulation for four weeks
Number of subjects: 14
Study 36151010 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 Hz stimulation
Number of subjects: 14
Study 36151010 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled analysis of 40 Hz and 4000 Hz
Number of subjects: 14
Study 34259408 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined moxibustion
Number of subjects: 150
Study 34259408 — intervention group
Group type: COMPARATOR
Intervention: Box-moxibustion
Number of subjects: 150
Study 34259408 — intervention group
Group type: COMPARATOR
Intervention: Chinese medication
Number of subjects: 150
Study 36399383 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (END)
Number of subjects: 68
Study 36399383 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RES)
Number of subjects: 68
Study 34359996 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-defined medial perimeniscal synovitis
Number of subjects: 447
Study 34359996 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprapatellar synovitis
Number of subjects: 447
Study 34359996 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher concentration of serum C3M
Number of subjects: 447
Study 34359996 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher concentration of serum CRPM
Number of subjects: 447
Study 34359996 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest CRPM quartile
Number of subjects: 447
Study 32470923 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (70-ml, containing ∼4.1 mmol of nitrate)
Number of subjects: 70
Study 32470923 — intervention group
Group type: COMPARATOR
Intervention: Placebo (70-ml, containing ∼0.04 mmol of nitrate)
Number of subjects: 70
Study 32470923 — intervention group
Group type: COMPARATOR
Intervention: Comparison between beetroot juice and placebo
Number of subjects: 70
Study 34743579 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab (70 or 140 mg/month)
Number of subjects: 777
Study 34743579 — intervention group
Group type: COMPARATOR
Intervention: Topiramate (50-100 mg/day)
Number of subjects: 777
Study 33297409 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorogenic acids (CGAs) 270 mg tablets
Number of subjects: 82
Study 33297409 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 33790860 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting octreotide or lanreotide monotherapy for ≥4 months
Number of subjects: 91
Study 32183498 — intervention group
Group type: EXPERIMENTAL
Intervention: MPM
Number of subjects: 20
Study 32183498 — intervention group
Group type: COMPARATOR
Intervention: β‐TCP
Number of subjects: 20
Study 34773794 — intervention group
Group type: EXPERIMENTAL
Intervention: Tipifarnib
Number of subjects: 144
Study 34773794 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 144
Study 34494106 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (400 mg/d)
Number of subjects: 112
Study 34494106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 34494106 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 112
Study 32006087 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethosuximide (500, 1000, or 1500 mg)
Number of subjects: 80
Study 32006087 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethosuximide (1500 mg/day)
Number of subjects: 80
Study 32006087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 35378119 — intervention group
Group type: EXPERIMENTAL
Intervention: High-definition transcranial direct current stimulation (HD-tDCS) of 2 mA for 15 min
Number of subjects: 0
Study 35378119 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 33259935 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative Volumetric Arc Therapy (VMAT)
Number of subjects: 69
Study 33259935 — intervention group
Group type: COMPARATOR
Intervention: 3-Dimensional Conventional Radiation Therapy (3DCRT)
Number of subjects: 69
Study 32248594 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine (1.54%) spray, used three times a day for 3 months
Number of subjects: 40
Study 32248594 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine (1.54%) spray
Number of subjects: 40
Study 32248594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33721085 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured skills training group (SSTG) based on dialectical behavioural therapy
Number of subjects: 184
Study 33721085 — intervention group
Group type: COMPARATOR
Intervention: Active control group based on psychoeducation
Number of subjects: 184
Study 33721085 — intervention group
Group type: COMPARATOR
Intervention: Both groups (SSTG and control)
Number of subjects: 184
Study 34672201 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates training program (36 sessions, 60 min each, 3 times a week for 12 weeks)
Number of subjects: 54
Study 34672201 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained normal activities)
Number of subjects: 54
Study 35653225 — intervention group
Group type: EXPERIMENTAL
Intervention: Isatuximab plus carfilzomib and dexamethasone (Isa-Kd)
Number of subjects: 86
Study 33141609 — intervention group
Group type: COMPARATOR
Intervention: Empagliflozin (SGLT2 inhibitor)
Number of subjects: 0
Study 33141609 — intervention group
Group type: COMPARATOR
Intervention: Dapagliflozin (SGLT2 inhibitor)
Number of subjects: 0
Study 33244331 — intervention group
Group type: EXPERIMENTAL
Intervention: Good knowledge about STIs
Number of subjects: 453
Study 33244331 — intervention group
Group type: EXPERIMENTAL
Intervention: Being male
Number of subjects: 453
Study 33244331 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased year of study
Number of subjects: 453
Study 33244331 — intervention group
Group type: EXPERIMENTAL
Intervention: Having one or no sexual partner
Number of subjects: 453
Study 33244331 — intervention group
Group type: EXPERIMENTAL
Intervention: Source of information from mass media (Television/Radio)
Number of subjects: 453
Study 35428357 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive 4D-ultrasound intervention (three interactive ultrasound examinations)
Number of subjects: 100
Study 32108382 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin patches of Xin Huang Pian
Number of subjects: 61
Study 32108382 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac Diethylamine Emulgel
Number of subjects: 61
Study 33453692 — intervention group
Group type: EXPERIMENTAL
Intervention: Reappraisal strategy
Number of subjects: 78
Study 33453692 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction strategy
Number of subjects: 78
Study 33453692 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance strategy
Number of subjects: 78
Study 33453692 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no regulation)
Number of subjects: 78
Study 33453692 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions (skin conductance)
Number of subjects: 78
Study 34844893 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 36
Study 34844893 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid (CS; cortivazol) injection
Number of subjects: 36
Study 33711748 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender essential oil massage (4 sessions)
Number of subjects: 112
Study 33711748 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 112
Study 32876497 — intervention group
Group type: EXPERIMENTAL
Intervention: NI-RADS category 1
Number of subjects: 158
Study 32876497 — intervention group
Group type: EXPERIMENTAL
Intervention: NI-RADS category 2a
Number of subjects: 158
Study 32876497 — intervention group
Group type: EXPERIMENTAL
Intervention: NI-RADS category 2b
Number of subjects: 158
Study 32876497 — intervention group
Group type: EXPERIMENTAL
Intervention: NI-RADS category 3
Number of subjects: 158
Study 32876497 — intervention group
Group type: EXPERIMENTAL
Intervention: NI-RADS category 4
Number of subjects: 158
Study 32876497 — intervention group
Group type: EXPERIMENTAL
Intervention: NI-RADS category 2
Number of subjects: 158
Study 32876497 — intervention group
Group type: EXPERIMENTAL
Intervention: NI-RADS overall performance
Number of subjects: 158
Study 32876497 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-reader agreement
Number of subjects: 158
Study 35681488 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic-Activated Cell Sorting (MACS) after density gradient centrifugation (DGC) in 90 thawed semen donor samples (MACSG)
Number of subjects: 181
Study 35681488 — intervention group
Group type: COMPARATOR
Intervention: Only density gradient centrifugation (DGC) in 91 thawed semen donor samples (CG)
Number of subjects: 181
Study 32393152 — intervention group
Group type: EXPERIMENTAL
Intervention: Kin KeeperSM Cancer Prevention Intervention (culturally-targeted breast and cervical cancer literacy tool, two family-focused education sessions)
Number of subjects: 516
Study 32393152 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly communicative families
Number of subjects: 516
Study 32393152 — intervention group
Group type: EXPERIMENTAL
Intervention: Family history of cancer
Number of subjects: 516
Study 34726121 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint Resources–Sedentary Behaviour (JR‐SB) intervention
Number of subjects: 467
Study 34726121 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher educational level and absence of comorbidity
Number of subjects: 467
Study 34209833 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS (2‐mA current in the M1 area for 20 min)
Number of subjects: 13
Study 34209833 — intervention group
Group type: COMPARATOR
Intervention: Sham trial (current turned off after 5 s)
Number of subjects: 13
Study 32576219 — intervention group
Group type: EXPERIMENTAL
Intervention: SD-101 6% cream
Number of subjects: 169
Study 32576219 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (0% allantoin)
Number of subjects: 169
Study 35490136 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical rapid maxillary expansion (RME)
Number of subjects: 38
Study 35490136 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgically assisted rapid maxillary expansion (SARME)
Number of subjects: 38
Study 34379946 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprietary combination (phenyl ethyl resorcinol, nonapeptide-1, aminoethyl phosphinic acid, antioxidants and sunscreen)
Number of subjects: 46
Study 34379946 — intervention group
Group type: COMPARATOR
Intervention: Sunscreen alone
Number of subjects: 46
Study 36212116 — intervention group
Group type: EXPERIMENTAL
Intervention: Counsellor-supported PTSD Coach Online (PCO)
Number of subjects: 20
Study 36212116 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment as usual
Number of subjects: 20
Study 36212116 — intervention group
Group type: EXPERIMENTAL
Intervention: Counsellor-supported PTSD Coach Mobile App
Number of subjects: 20
Study 36212116 — intervention group
Group type: COMPARATOR
Intervention: Self-managed PTSD Coach Mobile App
Number of subjects: 20
Study 34654903 — intervention group
Group type: EXPERIMENTAL
Intervention: Mydriatic microdrops (phenylephrine 1.67% and tropicamide 0.33%)
Number of subjects: 25
Study 34654903 — intervention group
Group type: COMPARATOR
Intervention: Standard drops (phenylephrine 1.67% and tropicamide 0.33%)
Number of subjects: 25
Study 32019854 — intervention group
Group type: EXPERIMENTAL
Intervention: Reparixin
Number of subjects: 75
Study 35711112 — intervention group
Group type: EXPERIMENTAL
Intervention: Cenobamate
Number of subjects: 0
Study 35711112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34378307 — intervention group
Group type: EXPERIMENTAL
Intervention: BAX‐HI (1 U/mL)
Number of subjects: 58
Study 34378307 — intervention group
Group type: COMPARATOR
Intervention: NOVO‐HI (100 U/mL diluted to 1 U/mL)
Number of subjects: 58
Study 32512785 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-water immersion for 20 minutes
Number of subjects: 12
Study 32512785 — intervention group
Group type: COMPARATOR
Intervention: Cold-water immersion for 20 minutes
Number of subjects: 12
Study 32512785 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-water immersion
Number of subjects: 12
Study 32512785 — intervention group
Group type: COMPARATOR
Intervention: Cold-water immersion
Number of subjects: 12
Study 32940132 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-layer closure (SLC)
Number of subjects: 51
Study 32940132 — intervention group
Group type: COMPARATOR
Intervention: Triple-layer closure (TLC)
Number of subjects: 51
Study 33577138 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructor-to-student ratio of 1:6
Number of subjects: 121
Study 33577138 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructor-to-student ratio of 1:8
Number of subjects: 121
Study 33577138 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructor-to-student ratio of 1:10
Number of subjects: 121
Study 33577138 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups surveyed
Number of subjects: 121
Study 35576285 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular Ketorolac
Number of subjects: 133
Study 35576285 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular Lignocaine
Number of subjects: 133
Study 33800577 — intervention group
Group type: EXPERIMENTAL
Intervention: ME + BCAAs
Number of subjects: 35
Study 33800577 — intervention group
Group type: EXPERIMENTAL
Intervention: ME
Number of subjects: 35
Study 33800577 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAAs
Number of subjects: 35
Study 33800577 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 35
Study 34890532 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise training programme (moderate intensity combination aerobic/resistance exercise training programme)
Number of subjects: 59
Study 34890532 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 59
Study 34890532 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training programme
Number of subjects: 59
Study 36399379 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated virtual reality cognitive therapy (gameChange)
Number of subjects: 346
Study 36399379 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 346
Study 35870440 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderated drinking recovery narrative
Number of subjects: 489
Study 35870440 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous symptom narrative + Moderated drinking recovery narrative
Number of subjects: 489
Study 35870440 — intervention group
Group type: COMPARATOR
Intervention: Dichotomous symptom narrative + Abstinence recovery narrative
Number of subjects: 489
Study 35870440 — intervention group
Group type: COMPARATOR
Intervention: Continuous symptom narrative + Abstinence recovery narrative
Number of subjects: 489
Study 35870440 — intervention group
Group type: COMPARATOR
Intervention: Dichotomous symptom narrative + Moderated drinking recovery narrative
Number of subjects: 489
Study 33754400 — intervention group
Group type: EXPERIMENTAL
Intervention: Adventure-based training (2-day/1-night)
Number of subjects: 228
Study 33754400 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group (2 days of leisure activities)
Number of subjects: 228
Study 35396311 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD-related video decision aid followed by recording personal video declarations about goals of care and treatment preferences
Number of subjects: 600
Study 35225371 — intervention group
Group type: EXPERIMENTAL
Intervention: DVP cutoff of 8 cm (DVP-Youden)
Number of subjects: 71893
Study 35225371 — intervention group
Group type: EXPERIMENTAL
Intervention: DVP cutoff of 10 cm (DVP-Percentile)
Number of subjects: 71893
Study 35225371 — intervention group
Group type: COMPARATOR
Intervention: DVP cutoffs compared against SMFM cutoffs (DVP-SMFM)
Number of subjects: 71893
Study 32885568 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (2 g combined probiotics daily)
Number of subjects: 28
Study 32885568 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 28
Study 34821494 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai chi
Number of subjects: 30
Study 34821494 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 32138760 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS care pathway
Number of subjects: 60
Study 32138760 — intervention group
Group type: COMPARATOR
Intervention: Traditional care pathway
Number of subjects: 60
Study 32308074 — intervention group
Group type: EXPERIMENTAL
Intervention: LED irradiation for 24 sessions (3 sessions per week) in addition to standard medical treatment
Number of subjects: 30
Study 32308074 — intervention group
Group type: COMPARATOR
Intervention: Standard medical treatment for 8 weeks
Number of subjects: 30
Study 33186337 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir Disoproxil Fumarate (TDF) intravaginal ring (IVR)
Number of subjects: 17
Study 33186337 — intervention group
Group type: COMPARATOR
Intervention: Placebo intravaginal ring (IVR)
Number of subjects: 17
Study 33802634 — intervention group
Group type: EXPERIMENTAL
Intervention: GDP arm
Number of subjects: 0
Study 33802634 — intervention group
Group type: EXPERIMENTAL
Intervention: DHAP arm
Number of subjects: 0
Study 35943252 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifapentine 600 mg daily (fixed dosing)
Number of subjects: 185
Study 35943252 — intervention group
Group type: COMPARATOR
Intervention: Weight-based dosing (10 mg/kg)
Number of subjects: 185
Study 35943252 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV)-based ART
Number of subjects: 185
Study 35943252 — intervention group
Group type: COMPARATOR
Intervention: Rifapentine and isoniazid regimen (1-month daily)
Number of subjects: 185
Study 34321504 — intervention group
Group type: EXPERIMENTAL
Intervention: VR SHMD
Number of subjects: 58
Study 34321504 — intervention group
Group type: COMPARATOR
Intervention: Smartphones
Number of subjects: 58
Study 32036837 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapamycin-eluting double stenting
Number of subjects: 126
Study 32036837 — intervention group
Group type: COMPARATOR
Intervention: Rapamycin-eluting single stenting
Number of subjects: 126
Study 34629430 — intervention group
Group type: EXPERIMENTAL
Intervention: Curettage + platelet-rich plasma gel
Number of subjects: 0
Study 34629430 — intervention group
Group type: COMPARATOR
Intervention: Curettage + crystallized phenol
Number of subjects: 0
Study 33932461 — intervention group
Group type: EXPERIMENTAL
Intervention: Diving method (500 mL of water administered every hour when the capsule reached the small bowel)
Number of subjects: 140
Study 33932461 — intervention group
Group type: EXPERIMENTAL
Intervention: Diving method
Number of subjects: 140
Study 33932461 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 140
Study 35066365 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided internet-based transdiagnostic individually tailored Cognitive Behavioral Therapy (iCBT)
Number of subjects: 100
Study 35066365 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 100
Study 35820845 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group - open discussion about patients' Advance Directives
Number of subjects: 58
Study 35820845 — intervention group
Group type: COMPARATOR
Intervention: Control group - evaluation of patients' clinical condition
Number of subjects: 58
Study 34673844 — intervention group
Group type: EXPERIMENTAL
Intervention: Amine fluoride, stannous chloride (ASC) toothpaste slurry
Number of subjects: 24
Study 34673844 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal (SBC) toothpaste slurry
Number of subjects: 24
Study 34673844 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride (SFL) toothpaste slurry
Number of subjects: 24
Study 34673844 — intervention group
Group type: EXPERIMENTAL
Intervention: All toothpastes
Number of subjects: 24
Study 32701116 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat 20 mg
Number of subjects: 0
Study 32701116 — intervention group
Group type: COMPARATOR
Intervention: Control group (no febuxostat)
Number of subjects: 0
Study 35431205 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized on-site exercise program including manual and exercise therapy from physiotherapy
Number of subjects: 56
Study 35431205 — intervention group
Group type: COMPARATOR
Intervention: Customized exercise sheets for a self-directed program at home
Number of subjects: 56
Study 33762661 — intervention group
Group type: EXPERIMENTAL
Intervention: Caralluma Fimbriata extract (CFE)
Number of subjects: 83
Study 33762661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 32877825 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 122
Study 32877825 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 122